SCHEMBL23426568

SCHEMBL23426568

Cc1cccc(C)c1-c1c2ccccc2c(-c2ccc3oc4cccc(-c5c6ccccc6c(-c6c(C)cccc6C)c6ccccc56)c4c3c2)c2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.36
▸ HPGD P15428 4/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ HSP90AB1 P08238 1/20 0.36
▸ ALOX5 P09917 1/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ MAOB P27338 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ PLA2G2A P14555 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23426836 0.96 PLA2G2A (0.37) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL23427267 0.89 HPGD (0.36) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL23426566 0.89 HSP90AA1 (0.38) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL23426935 0.89 ALOX5 (0.40) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL25575692 0.88 MAOB (0.43) ALDH1A1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL23426933 0.87 MAPT (0.45) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL24518934 0.87 ALOX5 (0.39) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL23426852 0.86 PLA2G2A (0.43) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL23426575 0.86 L3MBTL1 (0.35) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL23746759 0.86 ALDH1A1 (0.35) ALDH1A1HPGDKDM4ESMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11991927-B2 Organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-05-21 — — US disclosed
US-11991927-B2 Organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-05-21 — — US disclosed
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-21 — — US disclosed
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-21 — — US disclosed
US-20230174560-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 — — US disclosed
US-20230174560-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 — — US disclosed
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 — — US disclosed
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 — — US disclosed
US-20210249610-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-08-12 — — US disclosed
US-20210167299-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210167299-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, AOX1, OXER1 ALDH1A1 76/4885HPGD 1671/4885KDM4E 3450/4885
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP2E1, AOX1 ALDH1A1 43/4885HPGD 404/4885KDM4E 2489/4885
US-20230174560-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, AOX1, CYP1A1 ALDH1A1 11/4885HPGD 709/4885KDM4E 3046/4885
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, AOX1, CYP1A1 ALDH1A1 11/4885HPGD 676/4885KDM4E 2808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback